Clinical Trials Browser

Interventional × semaglutide × Clear all

NCT07202247 2026-02-04

Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial

Phase 2 Recruiting

Prostatic Neoplasms

NCT05819853 2025-08-28

RESTORE

Phase 3 Recruiting

Obesity, Polycystic Ovary Syndrome

NCT06908694 2025-07-29

GAINPCCONTROL

Phase 4 Recruiting

Prostatic Neoplasms

NCT06896981 2025-04-02

Semaglutide in Women With Polycystic Ovary Syndrome and Obesity

Phase 2/3 Recruiting

Obesity, Polycystic Ovary Syndrome

NCT06222437 2024-03-27

Semaglutide and Polycystic Ovarian Syndrome: an Emerging Treatment Strategy

Phase 1 Not yet recruiting

Polycystic Ovary Syndrome

NCT05702905 2024-03-25

Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome

Phase 4 Recruiting

Obesity, Polycystic Ovary Syndrome